Details
PrimateAI-3D and Splice AI, leading algorithms from the Illumina Artificial Intelligence Laboratory, are disrupting how we approach drug discovery and precision medicine. In this session we will review the data illustrating the impact that these two algorithms have on our understanding of variants of unknown significance (VUS) and the non-coding region of the genome – which can no longer be thought of as “junk.”
Speaker
Kyle Kai-How Farh, MD, PhD
VP & Distinguished Scientist, Illumina Artificial Intelligence Lab
Illumina
Dr. Kyle Kai-How Farh has been leading the Illumina Artificial Intelligence Lab for nine years. Prior to joining Illumina, Dr. Farh spent time as an attending physician at Boston Children’s Hospital and as a Fellow at The Broad Institute. He holds an MD from Harvard Medical School, a PhD in molecular biology from Massachusetts Institute of Technology, and a BS in computer science from Rice University.
Fill Out Form to Access Webinar
Your email address is never shared with third parties.
- Date & Time
- Apr 16, 2024
- Presenter
- Kyle Kai-How Farh, MD, PhD
- Topic
- Software & informatics